Click Therapeutics
*The future of medicine

Click Therapeutics sits at the center of biology + technology and body + mind. The company had established itself for over a decade on delivering novel software-based solutions that combine proven therapies with digital neuromodulatory mechanisms of action. In common terms, Click Therapeutics designs app-based programs to augment drug treatments for things like Major Depression Disorder, or Opioid Use Disorder.

Unlike competitors in the space that conflated their product’s interface with their brand (resulting in cutesy, digital companion identities), I wanted to position Click Therapeutics as the first digital biotech brand. A science-backed expert operating at the intersection of neuroscience and software, with its eyes on the cutting edge future of medicine.

As a result of the rebrand, Click expanded its business model beyond standalone software by launching Click SE, moving into "Software-Enhanced Drug" therapies that combine apps with pharmaceuticals.

Repositioning paved the way for vital regulatory milestones, including FDA marketing authorization for CT-132 (episodic migraine) and Breakthrough Device Designation for pipeline products.

Creative Partner—BASE

[Brand Territories, Brand Positioning, Tone & Feel, Copywriting]